咯血患者体循环动脉-肺血管瘘的临床特征及术后结局
回顾性纳入2011年9月至2019年5月在本院因咯血接受支气管动脉栓塞术的420例连续患者,按DSA分为伴与不伴体循环动脉-肺血管瘘(SA-PF)两组。伴SA-PF者184例(43.7%),肺炎作为合并症的可能性更低(p<0.001),人均责任动脉数更多(p=0.017),咯血复发风险更高(HR 2.782,95%CI 1.617-4.784,p<0.001);SA-肺静脉瘘利于降低复发率(HR 0.199,95%CI 0.052-0.765,p=0.019);优化CTA对SA-肺动脉瘘检出率为65.3%(49/75)。
要点
- SA-PF是BAE术后早期咯血复发的独立危险因素(HR 2.782)。
- SA-肺静脉瘘较SA-肺动脉瘘更利于延长咯血控制(HR 0.199)。
- 优化CTA对SA-肺动脉瘘检出率为65.3%(49/75)。
核心结论
- SA-PF的存在是预测BAE术后早期咯血复发的独立危险因素;与SA-肺动脉瘘相比,SA-肺静脉瘘似乎是延长咯血控制的保护因素;优化术前CTA是识别SA-肺动脉瘘的可靠检查。
研究设计与样本
- 回顾性纳入2011年9月至2019年5月在本院因咯血接受BAE的420例连续患者,按DSA所见分为伴SA-PF组与不伴SA-PF组,收集临床特征、术前CTA所见、BAE术中所见及随访结局。
关键影像表现/征象
- 伴SA-PF患者184例(43.7%),肺炎作为合并症的可能性更低(p<0.001)。
- 伴SA-PF患者人均责任动脉数显著多于不伴SA-PF者(p=0.017)。
- 优化CTA对SA-肺动脉瘘的检出率为65.3%(49/75)。
诊断标准与关键数值
- 以DSA为参考将患者分为伴SA-PF与不伴SA-PF两组。
- 伴SA-PF者咯血复发风险HR 2.782(95%CI 1.617-4.784,p<0.001)。
- SA-肺静脉瘘者咯血复发率HR 0.199(95%CI 0.052-0.765,p=0.019)。
- 优化CTA对SA-肺动脉瘘检出率65.3%(49/75)。
临床应用与阅片要点
- 术前识别SA-PF有助于预判BAE术后早期咯血复发风险。
- 优化CTA可作为识别SA-肺动脉瘘的辅助检查。
- 区分SA-肺动脉瘘与SA-肺静脉瘘对预后判断有参考价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the clinical characteristics and outcomes on the success of bronchial arterial embolization (BAE) in patients with and without systemic artery-to-pulmonary vessel fistula (SA-PF) and to evaluate the feasibility of CTA in the assessment of SA-PF.
METHODS: We retrospectively enrolled 420 consecutive patients that underwent BAE for hemoptysis control in our hospital from September 2011 to May 2019. The clinical characteristics, preprocedural CTA findings, BAE procedural findings, and follow-up outcomes were collected. Patients were divided into two groups according to DSA findings: patients with SA-PF and those without.
RESULTS: A total of 184 (43.7%) patients presented with SA-PF. Pneumonia was less likely to be the concomitant condition in patients with SA-PF (p < 0.001). The mean number of culprit arteries per patient was significantly higher in patients with SA-PF compared to that in patients without SA-PF (p = 0.017). The SA-PF patients saw a greater probability of recurrence (HR: 2.782, 95% CI: 1.617-4.784, p < 0.001). SA-pulmonary venous fistula (SA-PVF) favored lower hemoptysis recurrence rate (HR: 0.199, 95%CI: 0.052-0.765, p = 0.019). SA-pulmonary artery fistula (SA-PAF) can be detected by optimized CTA protocol with a detection rate of 65.3% (49/75).
CONCLUSIONS: The presence of SA-PF is an independent risk factor predicting early recurrence of hemoptysis after BAE. SA-PVF seems to be a protective factor for longer hemoptysis control compared to SA-PAF. Optimized preprocedural CTA is a reliable examination to identify SA-PAF.
KEY POINTS: • The appearance of SA-PF is associated with a greater probability of early recurrent hemoptysis after bronchial artery embolization. • The presence of SA-PVF seems to be a protective factor for longer hemoptysis control after BAE compared to SA-PAF. • Optimized CTA protocol seems to be a promising auxiliary examination to detect SA-PAF.
引用
- Zhang, Jiang, Zuo, et al. Clinical characteristics and postoperative outcomes of systemic artery-to-pulmonary vessel fistula in hemoptysis patients. Eur Radiol. 2022. PMID: 35029731. doi:10.1007/s00330-021-08484-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。